Enhancement of human NK and LAK cytotoxicity against HCMV-infected cells by rhamnogalacturonan: Specificity of reaction

Viral Immunology

Volumn 9, Issue 1, 1996, Pages 27-34

  Steinmassl, Max ^a   Anderer, F Alfred ^a  

^a FRIEDRICH MIESCHER LABORATORY OF THE MAX PLANCK SOCIETY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CELL RECEPTOR; MANNOSE; POLYGALACTURONIC ACID;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LYMPHOKINE ACTIVATED KILLER CELL; MONONUCLEAR CELL; NATURAL KILLER CELL; TARGET CELL; VIRUS INFECTION;

HUMAN HERPESVIRUS 5;

EID: 0030013347     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1996.9.27     Document Type: Article

References (33)

1. Apperley, J.F., and J.M. Goldman. 1988. Cytomegalovirus: Biology, clinical features and methods for diagnosis. Bone Marrow Transplant. 3:253-264.
2. Apperley, J.F., C. Dowding, J. Hibbin, J. Buiter, E. Matutes, P.J. Sissons, M. Gordon, and J.M. Goldman. 1989. The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp. Hematol. 17:38-45.
3. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21(Suppl. 97):77-79.
4. Crawford, D.H., N. Mulholland, V. Iliescu, R. Hawkins, and R. Powles. 1986. Epstein-Barr infection and immunity in bone marrow transplant recipients. Transplantation 42:50-54.
5. Diamond, R.D., R. Keller, G. Lee, and D. Finkel. 1977. Lysis of cytomegalo-virus-infected human fibroblasts and transformed human cells by peripheral blood lymphoid cells from normal human donors. Proc. Soc. Exp. Biol. Med. 154:259-263.
6. Duncombe, A.S., J.E. Grundy, H.G. Prentice, D.J. Gottlieb, P. Oblakowski, D. Roy, A.V. Hoffvrand, and M.K. Bramer. 1990. Expression of LFA1 correlates with increased cytotoxic sensitivity of EBV compared with CMV-infeted targets after BMI. Blood 76:2132-2139.
7. Hamprecht, K., W. Voetsch, and F.A. Anderer. 1986. Activation of human monocyte and natural killer cell-mediated cell killing by two dialysable thymic factors. Scand. J. Immunol. 24:56-71.
8. Hamprecht, K., R. Handgretinger, W. Voetsch, and F.A. Anderer. 1987. Mediation of human NK activity by components in extracts of Viscum album. Int. J. Immunopharmacol. 9:199-209.
9. Herberman, R.B., M.E. Nunn, H.T. Holden, S. Staal, and J.Y. Djeu. 1977. Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngenic and allogenic targets. Int. J. Cancer 19:555-564.
10. Korzeniweski, C., and D.M. Callewaert. 1983. An enzyme release assay for natural cytotoxicity. J. Immunol. Methods 64:313-322.
11. Livnat, S., M. Seigneuret, R., Storb, and R.L. Prentice. 1980. Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anaemia before and after marrow transplantation. J. Immunol. 124:481-490.
12. Meyers, J.D., N. Flournoy, J.C. Wade, R.C. Hackman, K. McDougall, P.E. Neiman, and E.D. Thomas. 1983. Biology of interstitial pneumonia after marrow transplantation, P. 405. In R.P. Gale (ed.): Recent advances in bone marrow transplantation. Liss, New York.
13. Meyers, J.D., N. Flournoy, and E.D. Thomas. 1986. Risk factors for cytome galovirus infection after human marrow transplantation. J. Infect. Dis. 153:478-488.
14. Mueller, E.A., and F.A. Anderer. 1990. Chemical specificity of effector cell/tumor cell bridging by a Viscum album rhamnogalacturonan enhancing cytotoxicity of human NK cells. Immunopharmacology 19:69-77.
15. Mueller, E.A., and F.A. Anderer. 1990. Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: Chemical specificity of target cell recognition. Cancer Res. 50:3646-3651.
16. Mueller, E.A., K. Hamprecht, and F.A. Anderer. 1989. Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicity. Immunopharmacology 17:11-18.
17. Rakusan, T.A., H.S. Juneja, and W.R. Fleischmann. 1989. Inhibition of hemopoietic colony formation by human CMV in vitro. J. Infect. Dis. 159:127-130.
18. Reittie, J.E., D. Gottlieb, H.E. Heslop, O. Leger, H.G. Drexler, G. Hazlehurst, A.V. Hoffbrand, H.G. Prentice, and M.K. Brenner. 1989. MK. Endogenously generated activated killer cells circulate after autologous and allogenic marrow transplantation but not after chemotherapy. Blood 73:1351-1358.
19. Reusser, P., S. Riddell, J.D. Meyers, and P.D. Greenberg. 1989. Generation of CMV-specific cytotoxic T lymphocyte precursors after allogenic bone marrow transplantation. Second Int. Cytomegalovirus Workshop, University of California, San Diego (abstr. 86).
20. Santoli, D., G. Trinchieri, and F.S. Lief. 1978. Cell-mediated cytotoxicity against virus-infected cells in humans. I. Characterization of the effector lymphocyte. J. Immunol. 121:526-531.
21. Starr, S.E. 1979. Cytomegalovirus. Pediatr. Clin. North Am. 26:283-299.
22. Steinmassl, M., and K. Hamprecht. 1994. Double fluorescence analysis of human cytomegalovirus-infected human fibroblast cultures by flow cytometry: Increase of class I MHC expression on uninfected cells and decrease on infected cells. Arch. Virol. 135:75-87.
23. + NK and LAK cells. Scand. J. Immunol. 40:665-668.
24. Trinchieri, G., D. Granato, and B. Perussia. 1981. Interferon induced resistance of fibroblasts to cytolysis mediated by natural killer cells: Specificity and mechanism. J. Immunol. 126:335-340.
25. Welsh, R.M. 1978. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J. Exp. Med. 148:163-181.
26. Welsh, R.M. 1986. Regulation of virus infections by natural killer cells. A review. Natl. Immunol. Cell Growth Regul. 5:159-199.
27. Welsh, R.M., and R.M. Zinkernagel. 1977. Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocyte choriomeningitis virus infection in mice. Nature (London) 268:646-648.
28. Wingard, J.R., D. Yen-Hung Chen, W.H. Burus, D.J. Fuller, H.G. Braine, A.M. Yeager, H. Kaiser, P.J. Burke, M.L. Graham, G.W. Santos, and R. Saral. 1988. Cytomegaloinfection after autologous bone marrow transplantation with comparison to infection after allogenic bone marrow transplantation. Blood 71:1432-1437.
29. Hauer, J., W. Voetsch, and F.A. Anderer. 1994. Identification of a mannose acetate-specific 87kDa receptor responsible for human NK and LAK activity. Immunol. Lett. 42:7-12.
30. Bezouska, K., C.T. Yuen, J. O'Brian, R.A. Childs, W. Chai, A.M. Lawson, K. Drbal, A. Fiserova, M. Pospisil, and T. Feizi. 1994. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature (London) 372:150-157.
31. Anchini, A., R. Mortarini, R. Supino, and G. Parmiani. 1990. Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive ability. Int. J. Cancer 46:508-515.
32. Timonen, T., G.G. Gahmberg, and M. Patarroyo. 1990. Participation of CD11 a-c/CD 18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3 negative large granular lymphocytes. Int. J. Cancer 46:1035-1040.
33. + T cells by rhamnogalacturonan: Target cell specificity and activity against NK-insensitive targets. J. Cancer Res. Clin. Oncol. 120:383-388.